Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACRL.L Regulatory News (ACRL)

  • There is currently no data for ACRL

Board and Board Committee Changes

29 Oct 2018 11:24

RNS Number : 5468F
Accrol Group Holdings PLC
29 October 2018
ย 

ย 

For immediate release on 29 October 2018

ย 

Accrol Group Holdings plc

("Accrol Group" or the "Company")

AIM: ACRL

ย 

Board and Board Committee Changes

ย 

Accrol Group, the UK's leading independent tissue converter, announces that Joanne Lake has given notice that she wishes to step down from the Board and leave the Company with effect from today to pursue other opportunities, alongside her existing portfolio of chairman and non-executive director responsibilities.

Simon Allport, who joined the Board on 10 October 2018, replaces Joanne as Chairman of the Audit Committee with immediate effect.

Following Joanne's departure, the Directors will continue discussions with other potential non-executive directors to further strengthen the Board in due course.

Dan Wright, Executive Chairman of Accrol Group, said:ย "I would like to thank Joanne for her contribution to the Board, particularly during the two fundraisings that wereย undertakenย to secure the future of the business.ย On behalf of the Board, I wish her all the best for the future."

ย 

For further information, please contact:

ย 

ย 

ย 

Accrol Group Holdings plc

ย 

Dan Wright, Executive Chairman

Tel: +44 (0) 1254 278 844

Gareth Jenkins, Chief Executive Officer

ย 

Steve Townsley, Chief Financial Officer

ย 

ย 

ย 

Zeus Capital Limited (Nominated Adviser & Broker)ย 

ย 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

ย 

ย 

Belvedere Communications Limited

ย 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

Llew Angus (langus@belvederepr.com)

Tel: +44 (0) 7407 023 147

ย 

ย 

ย 

Notes to Editors

ย 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.ย 

ย 

Accrol operates from three sites:

ย 

ยท A manufacturing, storage and distribution facility in Blackburn;

ยท A facial tissue plant, also in Blackburn; and

ยท A manufacturing, storage and distribution facility in Leyland.

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
ย 
END
ย 
ย 
BOAUKUARWOARUAA
Date   Source Headline
26th Jun 20179:06 amRNSInvestment in new manufacturing line for Leyland
23rd Jun 201710:15 amEQSLily & Piper Limited: Small Cap Awards 2017
16th May 20177:00 amRNSTrading Update, New Facilities & Notice of Results
6th Apr 201712:00 pmRNSOfficial opening of new manufacturing facility
9th Jan 20173:43 pmRNSHolding(s) in Company
4th Jan 20177:00 amRNSInterim results for six months ended 31 Oct 2016
14th Dec 20167:00 amRNSNotice of interim results date change
7th Nov 20167:00 amRNSPre-close trading statement
30th Sep 201612:07 pmRNSResult of AGM
29th Sep 20164:33 pmRNSDirector's Dealing
22nd Sep 20161:06 pmRNSHolding(s) in Company
2nd Sep 20167:00 amRNSNew manufacturing facility
4th Aug 20164:56 pmRNSHolding(s) in Company
22nd Jul 20167:00 amRNSFull year results for the year ended 30 April 2016
11th Jul 20167:00 amRNSDeferred Share Buyback
8th Jul 20167:00 amRNSContract Win and Trading Update
14th Jun 20165:12 pmRNSHolding(s) in Company
13th Jun 20166:18 pmRNSHolding(s) in Company
13th Jun 20166:01 pmRNSHolding(s) in Company
13th Jun 20165:57 pmRNSHolding(s) in Company
13th Jun 20164:03 pmRNSHolding(s) in Company
13th Jun 20161:45 pmRNSHolding(s) in Company
13th Jun 201612:28 pmRNSHolding(s) in Company
10th Jun 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.